Pharmacology in vivo of the phenylindan derivative, lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain-Reference-Cited by-同舟云学术

Pharmacology in vivo of the phenylindan derivative, lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain

Published:1985-04 Issue:2 Volume:329 Page:101-107
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch. Pharmacol.

Author:

Arnt J�rn,Christensen Anne Vibeke,Hyttel John

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00501197.pdf

Reference39 articles.

1. Anders MW (1971) Enhancement and inhibition of drug metabolism. Ann Rev Pharm 11:37?56

2. Antelman SM, Chiodo LA (1981) Dopamine autoreceptor subsensitivity: A mechanism common to the treatment of depression and the induction of amphetamine psychosis? Biol Psychiatr 16:717?727

3. Arnt J, Christensen AV (1981) Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics. Eur J Pharmacol 69:107?111

4. Arnt J; Hyttel J. Fredricson Over� K (1984) Prolonged treatment with the specific 5-HT-uptake-inhibitor citalopram: Effect on dopaminergic and serotonergic functions. Pol J Pharmacol Pharm 36:217?226

5. B�ges� KP, Christensen AV, Hyttel J, Liljefors T (1985) 3-Phenyl-l-indanamines potential antidepressant activity and potent inhibition of dopamine, norepinephrine, and serotonin uptake. J Med Chem (in press)

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of anti-depressant molecules via metal-catalyzed reactions: a review;RSC Advances;2024

2. Predict New Therapeutic Drugs for Hepatocellular Carcinoma Based on Gene Mutation and Expression;Frontiers in Bioengineering and Biotechnology;2020-01-28

3. Antinociceptive activity of the new triple reuptake inhibitor NS 18283 in a mouse model of chemotherapy‐induced neuropathic pain;European Journal of Pain;2015-03

4. A comparative review of escitalopram, paroxetine, and sertraline;International Clinical Psychopharmacology;2014-07

5. Triple reuptake inhibitors: a patent review (2006 – 2012);Expert Opinion on Therapeutic Patents;2013-11-30